Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 7/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.43 |
| ▸ | MAPT | P10636 | 6/20 | 0.43 |
| ▸ | LMNA | P02545 | 5/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13700778 | 0.89 | L3MBTL1 (0.55) | L3MBTL1MEN1KMT2AMAPTLMNA | |
| SCHEMBL13776848 | 0.88 | MEN1 (0.51) | L3MBTL1MEN1KMT2AMAPTLMNA | |
| SCHEMBL13700782 | 0.87 | L3MBTL1 (0.57) | L3MBTL1MEN1KMT2AMAPTLMNA | |
| SCHEMBL13776864 | 0.81 | MEN1 (0.56) | L3MBTL1MEN1KMT2AMAPTLMNA | |
| SCHEMBL13776901 | 0.81 | MEN1 (0.56) | L3MBTL1MEN1KMT2AMAPTLMNA | |
| SCHEMBL22722728 | 0.81 | L3MBTL1 (0.52) | L3MBTL1MEN1KMT2AMAPTLMNA | |
| SCHEMBL24372678 | 0.80 | L3MBTL1 (0.61) | L3MBTL1MEN1KMT2AMAPTLMNA | |
| SCHEMBL18180978 | 0.79 | L3MBTL1 (0.50) | L3MBTL1MEN1KMT2AMAPTLMNA | |
| SCHEMBL19497361 | 0.79 | L3MBTL1 (0.50) | L3MBTL1MEN1KMT2AMAPTLMNA | |
| SCHEMBL13776852 | 0.79 | MEN1 (0.56) | L3MBTL1MEN1KMT2AMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8877355-B2 | Monoamine compound, charge-transporting material, and organic electroluminescent device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-11-04 | — | — | US | disclosed |
| US-20130214263-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-08-22 | — | — | US | disclosed |
| US-8427046-B2 | Monoamine compound, charge-transporting material, and organic electroluminescent device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-04-23 | — | — | US | disclosed |
| US-8324403-B2 | Carbazole derivatives; excellent hole transporting property and satisfactory electron transporting, excellent durability against electric oxidation/reduction and a high triplet excitation level; high luminous efficiency and a long lifetime | PIONEER CORPORATION (JP) | 2012-12-04 | — | — | US | disclosed |
| US-20090230846-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20090191426-A2 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORPORATION (JP) | 2009-07-30 | — | — | US | disclosed |
| US-20080145699-A1 | Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element | PIONEER CORPORATION (JP) | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090191426-A2 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | SLC39A3, SLCO2A1, SLC39A11 | L3MBTL1 1312/4885MEN1 2193/4885KMT2A 1792/4885 |
| US-20090230846-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | SLC7A5, SLC18A1, MAOA | L3MBTL1 1395/4885MEN1 2206/4885KMT2A 982/4885 |
| US-20080145699-A1 | Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element | SLC39A3, SLCO2A1, SLC39A11 | L3MBTL1 1312/4885MEN1 2193/4885KMT2A 1792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.